Susan H. Alexander

Susan H. Alexander filed 97 reports, from February 9, 2016 to February 10, 2026. Biogen Inc. accounts for 90 of them, under the title EVP Chief Legal Off & Corp Sec (chief legal officer and corporate secretary), and Invacare Corp for 7, as Director.

The record holds no purchase. Three sales, all at Biogen Inc., add up to EUR 4,714,524, with a median of EUR 1,557,848: EUR 1,917,892 on July 19, 2017, EUR 1,557,848 on October 27, 2022 and EUR 1,238,784 on July 25, 2017. Around them sit 52 share grants, 39 option exercises and 3 filings of another kind.

Annual volume ranges from 6 filings in 2025 to 11 in both 2017 and 2019. The year 2026 already has 6, which are all of the last twelve months, with no sale among them.

The count of trades by Alexander within 30 days of a colleague at Biogen Inc. is 1. On the same side. Colleague concerned: Ginger Gregory. The publication delay is a median of 4 days across 96 dated filings.